<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/4469</identifier>
				<datestamp>2020-02-06T08:56:41Z</datestamp>
				<setSpec>aabp:Post</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Comparison of the Immune Response between a Pair of Noncytopathic and Cytopathic Bovine Viral Diarrhea Virus (BVDV) Type 1 Isolates</dc:title>
	<dc:creator xml:lang="en">Chase, C. C. L.</dc:creator>
	<dc:creator xml:lang="en">Braun, L. J.</dc:creator>
	<dc:creator xml:lang="en">Ridpath, J.</dc:creator>
	<dc:creator xml:lang="en">Harland, R.</dc:creator>
	<dc:subject xml:lang="en">Bovine viral diarrhea virus</dc:subject>
	<dc:subject xml:lang="en">BVDV</dc:subject>
	<dc:subject xml:lang="en">immune responses</dc:subject>
	<dc:subject xml:lang="en">vaccination</dc:subject>
	<dc:subject xml:lang="en">re-infection</dc:subject>
	<dc:subject xml:lang="en">noncytopathic</dc:subject>
	<dc:subject xml:lang="en">cytopathic</dc:subject>
	<dc:description xml:lang="en">Bovine viral diarrhea virus (BVDV) is a major pathogen of cattle causing severe respiratory and reproductive disease. BVDV vaccines remain an important part of the control strategy. Previous work has described higher antibody responses in animals infected with a noncytopathic (NCP) BVDV when compared to its cytopathic (CP) BVDV pair. Animals were re-infected 90 days later with either the same biotype or the other biotype. The animals infected with NCP initially were protected to a higher degree against re-infection with either biotype when compared to the animals infected with CP initially. In this study we wanted to see the effect of an initial infection (or vaccination) with a type 1 NCP or CP BVDV pair followed by infection with a virulent type 2 BVDV on clinical signs and immune responses.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2008-09-25</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/aabp/article/view/4469</dc:identifier>
	<dc:identifier>10.21423/aabppro20084469</dc:identifier>
	<dc:source xml:lang="en">American Association of Bovine Practitioners  Conference Proceedings; 2008; 275</dc:source>
	<dc:source>1079-9737</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/aabp/article/view/4469/4376</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2008 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
